Carissa Low
@carissalow.bsky.social
Associate Professor of Medicine, Psychology, and Biomedical Informatics at the University of Pittsburgh; Director of the Pitt Mobile Sensing + Health Institute (www.moshi.pitt.edu)
Which daily symptoms during chemotherapy increase risk for ED visits or unplanned hospitalizations? In this paper led by recent MD Elizabeth Kairis, GI symptoms, shortness of breath, fatigue, & pain predicted risk of unplanned healthcare within the next 7 days: ascopubs.org/doi/10.1200/...
August 7, 2025 at 11:43 PM
Which daily symptoms during chemotherapy increase risk for ED visits or unplanned hospitalizations? In this paper led by recent MD Elizabeth Kairis, GI symptoms, shortness of breath, fatigue, & pain predicted risk of unplanned healthcare within the next 7 days: ascopubs.org/doi/10.1200/...
Can devices worn during chemotherapy capture prognostic information about physical function? We found that Fitbit metrics predicted overall survival, even after adjusting for clinician-rated performance status and patient-reported physical function:
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics
PURPOSEConsumer wearable devices provide new opportunities for measuring patterns of objective
daily physical activity throughout cancer treatment. In addition to capturing step
counts, these devices ...
ascopubs.org
July 11, 2025 at 8:47 PM
Can devices worn during chemotherapy capture prognostic information about physical function? We found that Fitbit metrics predicted overall survival, even after adjusting for clinician-rated performance status and patient-reported physical function:
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
Reposted by Carissa Low
Pitt Med School student Svea Cheng is first author on this study with PaRC faculty member Carissa Low which asks "What is a good day for a patient with advanced cancer?" Learn the answer, now online in Supportive Care in Cancer #hpm #research :
Exploring what constitutes "a good day" for individuals living with advanced cancer: a qualitative interview study - PubMed
This qualitative study highlighted common themes in what defines good and bad days living with stage IV cancer. Understanding individual values and priorities may help care teams support people with…
pubmed.ncbi.nlm.nih.gov
April 8, 2025 at 3:00 PM
Qualitative study led by extraordinary med student Svea Cheng explored the activities and experiences that characterize good days living with advanced cancer: link.springer.com/article/10.1...
April 7, 2025 at 4:09 PM
Qualitative study led by extraordinary med student Svea Cheng explored the activities and experiences that characterize good days living with advanced cancer: link.springer.com/article/10.1...
Reposted by Carissa Low
Key findings from @carissalow.bsky.social's study were that Fitbit metrics like gait speed were related to patient-reported and performance-based physical functioning as well as fall risk even after adjusting for age and comorbidities. #hpm #hapc Link:
Associations between performance-based and patient-reported physical functioning and real-world mobile sensor metrics in older cancer survivors: A pilot study - PubMed
This study provides preliminary evidence that real-world data from consumer devices may be useful for estimating functional performance among older cancer survivors and potentially for remotely and…
pubmed.ncbi.nlm.nih.gov
January 15, 2025 at 4:15 PM
Key findings from @carissalow.bsky.social's study were that Fitbit metrics like gait speed were related to patient-reported and performance-based physical functioning as well as fall risk even after adjusting for age and comorbidities. #hpm #hapc Link:
This paper, led by our amazing research coordinator Annie Bartel, describes initial efforts to visualize daily patient-reported symptom data alongside wearable sensor data collected from patients receiving chemotherapy. Patients who viewed their data most often were those new to chemotherapy.
New in JMIR Cancer: Design and Use of #Patient-Facing Electronic #Patient-Reported Outcomes and Sensor Data Visualizations During Out#Patient Chemotherapy
Design and Use of #Patient-Facing Electronic #Patient-Reported Outcomes and Sensor Data Visualizations During Out#Patient Chemotherapy
Summary Sentence This #Study describes #Patients’ interaction with a personalized #Patient-facing web visualization of daily ePRO symptoms and wearable device data during out#Patient chemotherapy.
dlvr.it
January 13, 2025 at 5:22 PM
This paper, led by our amazing research coordinator Annie Bartel, describes initial efforts to visualize daily patient-reported symptom data alongside wearable sensor data collected from patients receiving chemotherapy. Patients who viewed their data most often were those new to chemotherapy.
New paper led by David Lazris (PGY-3) used daily diaries to explore activities associated with having a "good day" among patients living with Stage IV cancer. Day-to-day QoL fluctuated for each patient, and the specific activities correlated with good days varied from patient to patient
January 10, 2025 at 8:36 PM
New paper led by David Lazris (PGY-3) used daily diaries to explore activities associated with having a "good day" among patients living with Stage IV cancer. Day-to-day QoL fluctuated for each patient, and the specific activities correlated with good days varied from patient to patient
First paper from our NCI R37, led by med student (now Triple Board Resident) Sean McClaine, is out! We found that daily symptom & behavior monitoring using smartphones & wearable devices is feasible during chemotherapy BUT engagement varied based on demographic, clinical, & time-related factors
New in JMIR Cancer: Engagement With Daily Symptom Reporting, Passive Smartphone Sensing, and Wearable Device Data Collection During Chemotherapy: Longitudinal Observational #Study
Engagement With Daily Symptom Reporting, Passive Smartphone Sensing, and Wearable Device Data Collection During Chemotherapy: Longitudinal Observational #Study
Background: Chemotherapy can cause symptoms that impair quality of life and functioning. Remote monitoring of daily symptoms and activity during out#Patient treatment may enable earlier detection and management of emerging toxicities but requires…
dlvr.it
January 6, 2025 at 8:56 PM
First paper from our NCI R37, led by med student (now Triple Board Resident) Sean McClaine, is out! We found that daily symptom & behavior monitoring using smartphones & wearable devices is feasible during chemotherapy BUT engagement varied based on demographic, clinical, & time-related factors